RecruitingNCT06923449

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance

Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance - The Experience of a High-volume Italian University Hospital

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

250 participants

Start Date

May 16, 2024

Study Type

OBSERVATIONAL

Conditions

Stomach Neoplasm

Summary

The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is analyzing outcomes for patients with stomach cancer who undergo surgery with the goal of curing the disease, and evaluating how well multidisciplinary tumor board reviews (meetings where specialists plan treatment together) influence those outcomes. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis of gastric adenocarcinoma (stomach cancer) - You are a candidate for surgery with curative intent **You may NOT be eligible if...** - Your cancer was treated only with endoscopic procedures (no surgery) - Your cancer is a type other than adenocarcinoma (such as sarcoma, lymphoma, or GIST) - Your cancer stage is unclear or incompletely evaluated - You presented as an emergency (e.g., blocked or perforated stomach) - You have another cancer that might affect survival outcomes - You are pregnant - You are under 18 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultidisciplinary Tumor Board

Institution of Multidisciplinary Tumor Board for Gastric Cancer at Fondazione Policlinico Gemelli in november 2019

Locations(1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, IT, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06923449

Related Trials

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

NCT051848031 location

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

NCT060857551 location

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

NCT071490901 location

Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

NCT0518086416 locations

[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer

NCT0701866110 locations